牙科生物材料市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024 年全球牙科生物材料市场价值为 84.5 亿美元，预计将经历强劲增长，到 2030 年年复合成长率(CAGR) 为 6.10%。近年来，牙科领域取得了长足的创新，从根本上重塑了口腔保健的方法。这一演变的核心是牙科生物材料的进步——旨在恢復、修復和增强牙齿结构的复杂物质。

这个市场的特点是快速创新，由广泛的研究、技术进步和公众对口腔健康重要性的认识不断提高所推动。有几个关键因素推动了市场的扩张，其中最重要的是蛀牙、牙周病和牙齿脱落等牙齿疾病的发生率不断上升。随着全球人口老化和对预防保健的重视程度不断提高，对有效、高性能牙科解决方案的需求正在上升。

关键市场驱动因素

牙齿疾病盛行率上升，口腔健康意识增强

主要市场挑战

监管复杂性和合规性要求

主要市场趋势

技术进步推动创新

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：牙科生物材料市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（金属生物材料、陶瓷生物材料、聚合物生物材料、金属陶瓷生物材料、天然生物材料、复合生物材料）
  • 按应用（正畸、种植、修復、其他）
  • 按最终用户（牙科医院和诊所、牙科实验室、牙科学院和研究机构、牙科产品製造商）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美牙科生物材料市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲牙科生物材料市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区牙科生物材料市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲牙科生物材料市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲牙科生物材料市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球牙科生物材料市场：SWOT 分析

第 14 章：竞争格局

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global dental biomaterials market was valued at USD 8.45 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 6.10% through 2030. The field of dentistry has seen substantial innovation in recent years, fundamentally reshaping the approach to oral healthcare. At the heart of this evolution lies the advancement of dental biomaterials-sophisticated substances designed to restore, repair, and enhance dental structures.

This market is characterized by rapid innovation, driven by extensive research, technological progress, and rising public awareness of oral health's significance. Several key factors are contributing to the market's expansion, foremost among them being the increasing incidence of dental conditions such as cavities, periodontal disease, and tooth loss. With an aging global population and a heightened focus on preventive care, the demand for effective, high-performance dental solutions is on the rise.

Key Market Drivers

Rising Prevalence of Dental Conditions and Growing Oral Health Awareness

One of the primary growth drivers of the global dental biomaterials market is the escalating prevalence of dental disorders alongside greater public awareness of oral health. Conditions such as dental caries, periodontitis, and tooth loss have become increasingly common, necessitating the use of durable, biocompatible, and high-performance biomaterials.

According to the Global Burden of Disease Report 2021, approximately 3.7 billion people globally are affected by oral diseases, positioning them as a significant public health concern. Among these, untreated dental caries in permanent teeth ranks as the most widespread health issue globally. This underscores the urgent demand for effective treatment solutions, including fillings, crowns, and root canals-all of which rely on advanced materials like composite resins, ceramics, and dental cements.

Furthermore, complete tooth loss affects an estimated 7% of individuals aged 20 and older, further highlighting the need for restorative dental solutions. Conditions such as gum recession and tooth mobility, which often result in tooth loss, have increased demand for regenerative biomaterials including soft tissue grafts and bone substitutes.

As the global population continues to age, the prevalence of edentulism (toothlessness) is rising, fueling demand for dental implants and prosthetics. This has subsequently increased the consumption of zirconia, titanium, and polymer-based materials, essential in modern implantology. These trends present significant opportunities for manufacturers of dental biomaterials focused on restorative, prosthetic, and preventive applications.

Key Market Challenges

Regulatory Complexity and Compliance Requirements

A major obstacle facing stakeholders in the dental biomaterials market is the stringent regulatory landscape. Like other medical-grade products, dental biomaterials must comply with rigorous safety and efficacy standards. Achieving regulatory approval entails extensive testing, documentation, and financial investment.

Moreover, divergent regulatory frameworks across regions pose additional challenges for manufacturers pursuing international market expansion. Navigating these complexities can significantly slow product development and market entry timelines.

Key Market Trends

Technological Advancements Driving Innovation

The dental biomaterials market encompasses a diverse range of materials-including metals, ceramics, polymers, and composites-each serving distinct roles in dental care procedures such as restorations, implants, orthodontics, and tissue regeneration.

Among the most transformative market trends is the advancement in manufacturing technologies. Tools such as Computer-Aided Design (CAD) and Computer-Aided Manufacturing (CAM) enable the production of precision dental prosthetics, including crowns, bridges, and implants. Additionally, 3D printing has emerged as a disruptive technology, allowing for rapid prototyping and the creation of patient-specific solutions with remarkable accuracy.

The field of biomimicry has also contributed to the development of dental materials that closely replicate the properties of natural teeth in terms of strength, aesthetics, and durability. Bioactive materials capable of promoting tissue regeneration and facilitating self-repair further enhance treatment outcomes and extend the longevity of dental restorations.

Nanotechnology is playing an increasingly important role as well, with nanoscale fillers improving the mechanical strength, esthetics, and antimicrobial properties of dental composites. These innovations are setting new standards in the quality and performance of dental restorations.

Meanwhile, digital dentistry is reshaping clinical workflows. Technologies such as intraoral scanners, digital radiography, and virtual treatment planning systems have enhanced diagnostic accuracy and treatment precision. These digital tools also support integrated patient data management, enabling more personalized and efficient care strategies.

Key Market Players

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

Report Scope:

In this report, the Global Dental Biomaterials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dental Biomaterials Market, By Type:

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

Dental Biomaterials Market, By Application:

• Orthodontics
• Implantology
• Prosthodontics
• Others

Dental Biomaterials Market, By End User:

• Dental Hospitals& Clinics
• Dental laboratories
• Dental Academies and Research Institutes
• Dental Product manufacturers

Dental Biomaterials Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dental Biomaterials Market.

Available Customizations:

Global Dental Biomaterials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Dental Biomaterials Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials)
  • 5.2.2. By Application (Orthodontics, Implantology, Prosthodontics, Others)
  • 5.2.3. By End User (Dental Hospitals & Clinics, Dental laboratories, Dental Academies and Research Institutes, Dental Product Manufacturers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Dental Biomaterials Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dental Biomaterials Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Dental Biomaterials Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Dental Biomaterials Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Dental Biomaterials Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dental Biomaterials Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Dental Biomaterials Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Dental Biomaterials Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Dental Biomaterials Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Dental Biomaterials Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Dental Biomaterials Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Dental Biomaterials Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Dental Biomaterials Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Dental Biomaterials Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Dental Biomaterials Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Dental Biomaterials Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Dental Biomaterials Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Dental Biomaterials Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Dental Biomaterials Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Dental Biomaterials Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Dental Biomaterials Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Dental Biomaterials Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Dental Biomaterials Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Dental Biomaterials Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Dental Biomaterials Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Institut Straumann AG
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Geistlich Pharma AG
• 14.3. Zimmer Biomet Holdings, Inc.
• 14.4. Danaher Corporation
• 14.5. Dentsply Sirona, Inc.
• 14.6. 3M Company
• 14.7. CRS Holdings, LLC.
• 14.8. Medtronic PLC
• 14.9. Henry Schein, Inc.
• 14.10.Mitsui Chemicals, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer